Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP4LEP chemoprophylaxis implementation trial
NL-OMON27622Recruiting
- Sponsor
- EDCTP
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rifampicin in leprosy (HD), Not applicable (entry is a general category, not a specific disease) and Neglected Infectious Diseases (NIDs) (2 arms), sponsored by EDCTP. Primary endpoints: Rate of leprosy patients detected, Delay in case detection and 2 more. Started Jan 2019; status: recruiting.
02
Drugs
rifampicin
03
Conditions
leprosy (HD)Not applicable (entry is a general category, not a specific disease)Neglected Infectious Diseases (NIDs)
Beyond the preview
Go deeper on NL-OMON27622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27622.